121 related articles for article (PubMed ID: 12145258)
1. GAD65 antibody epitope patterns of type 1.5 diabetic patients are consistent with slow-onset autoimmune diabetes.
Hampe CS; Kockum I; Landin-Olsson M; Törn C; Ortqvist E; Persson B; Rolandsson O; Palmer J; Lernmark A
Diabetes Care; 2002 Aug; 25(8):1481-2. PubMed ID: 12145258
[No Abstract] [Full Text] [Related]
2. A diabetes-related epitope of GAD65: a major diabetes-related conformational epitope on GAD65.
Myers MA; Fenalti G; Gray R; Scealy M; Tong JC; El-Kabbani O; Rowley MJ
Ann N Y Acad Sci; 2003 Nov; 1005():250-2. PubMed ID: 14679070
[TBL] [Abstract][Full Text] [Related]
3. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.
Hampe CS; Nalini R; Maldonado MR; Hall TR; Garza G; Iyer D; Balasubramanyam A
J Clin Endocrinol Metab; 2007 Feb; 92(2):462-7. PubMed ID: 17090641
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.
Falorni A; Gambelunghe G; Forini F; Kassi G; Cosentino A; Candeloro P; Bolli GB; Brunetti P; Calcinaro F
J Clin Endocrinol Metab; 2000 Jan; 85(1):309-16. PubMed ID: 10634404
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
[TBL] [Abstract][Full Text] [Related]
6. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.
Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Kockum I; Rolandsson O; Landin-Olsson M; Törn C; Persson B; Lernmark A
J Clin Endocrinol Metab; 2000 Dec; 85(12):4671-9. PubMed ID: 11134126
[TBL] [Abstract][Full Text] [Related]
7. The glutamate decarboxylase and 38KD autoantigens in type 1 diabetes: aspects of structure and epitope recognition.
Baekkeskov S; Aanstoot HJ; Fu Q; Jaffe M; Kim J; Quan J; Richter W; Shi Y
Autoimmunity; 1993; 15 Suppl():24-6. PubMed ID: 7692998
[No Abstract] [Full Text] [Related]
8. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.
Schlosser M; Banga JP; Madec AM; Binder KA; Strebelow M; Rjasanowski I; Wassmuth R; Gilliam LK; Luo D; Hampe CS
Diabetologia; 2005 May; 48(5):922-30. PubMed ID: 15834701
[TBL] [Abstract][Full Text] [Related]
9. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the humoral immune response to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and/or type 1 diabetes.
Ronkainen MS; Härkönen T; Perheentupa J; Knip M
Eur J Endocrinol; 2005 Dec; 153(6):901-6. PubMed ID: 16322397
[TBL] [Abstract][Full Text] [Related]
11. Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. The Childhood Diabetes in Finland Study Group.
Söhnlein P; Müller M; Syren K; Hartmann U; Böhm BO; Meinck HM; Knip M; Akerblom HK; Richter W
Diabetologia; 2000 Feb; 43(2):210-7. PubMed ID: 10753043
[TBL] [Abstract][Full Text] [Related]
12. GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.
Reijonen H; Daniels TL; Lernmark A; Nepom GT
Diabetes; 2000 Oct; 49(10):1621-6. PubMed ID: 11016444
[TBL] [Abstract][Full Text] [Related]
13. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
[TBL] [Abstract][Full Text] [Related]
14. Epitope analysis of GAD65 autoantibodies in Japanese patients with autoimmune diabetes.
Kawasaki E; Abiru N; Ide A; Sun F; Fukushima T; Takahashi R; Kuwahara H; Fujita N; Kita A; Oshima K; Uotani S; Yamasaki H; Yamaguchi Y; Eguchi K
Ann N Y Acad Sci; 2003 Nov; 1005():440-8. PubMed ID: 14679108
[TBL] [Abstract][Full Text] [Related]
15. BCG vaccination and GAD65 and IA-2 autoantibodies in autoimmune diabetes in southern India.
Sanjeevi CB; Das AK; Shtauvere-Brameus A
Ann N Y Acad Sci; 2002 Apr; 958():293-6. PubMed ID: 12021127
[TBL] [Abstract][Full Text] [Related]
16. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
[TBL] [Abstract][Full Text] [Related]
17. Isolation and functional characterization of recombinant GAD65 autoantibodies derived by IgG repertoire cloning from patients with type 1 diabetes.
Jury K; Söhnlein P; Vogel M; Richter W
Diabetes; 2001 Sep; 50(9):1976-82. PubMed ID: 11522662
[TBL] [Abstract][Full Text] [Related]
18. Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset.
Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Persson B; Lernmark A
J Autoimmun; 2002 Feb; 18(1):49-53. PubMed ID: 11869046
[TBL] [Abstract][Full Text] [Related]
19. Antigenic determinants to GAD autoantibodies in patients with type 1 diabetes with and without autoimmune thyroid disease.
Park H; Yu L; Kim T; Cho B; Kang J; Park Y
Ann N Y Acad Sci; 2006 Oct; 1079():213-9. PubMed ID: 17130557
[TBL] [Abstract][Full Text] [Related]
20. Multiplicity of the antibody response to GAD65 in Type I diabetes.
Gilliam LK; Binder KA; Banga JP; Madec AM; Ortqvist E; Kockum I; Luo D; Hampe CS
Clin Exp Immunol; 2004 Nov; 138(2):337-41. PubMed ID: 15498046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
